It’s no secret COVID is having a drastic impact on people’s well-being, and has worsened an already a rising trend in mental health problems. The Australian […]
American drugmaker Pfizer announced a deal on Monday to acquire Global Blood Therapeutics, makers of a recently approved treatment for sickle cell disease, for $5.4 billion.